Evidence map

ArticleCardiovascular diabetology2004

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?

Alexander Tenenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 15574199